SpyGlass Pharma
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigati...
Latest News
5 days ago · globenewswire.com
SpyGlass Pharma Reports Third Quarter 2026 Financial Results and Provides Corporate UpdatesIRVINE, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma” or “Company”), a late-stage biopharmaceutical company, today reported recent business highlights and financial results for the third quarter ended September 30, 2026.
12 days ago · globenewswire.com
SpyGlass Pharma to Participate in Upcoming Investor ConferencesIRVINE, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma” or “Company”), a late-stage biopharmaceutical company, today announced that members of the executive management team will participate in the following upcoming conferences: Stifel 2026 Healthcare Conference Date: Thursday, November 12, 2026Time: 8:00 a.m.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove SGP